EuroAPI Header EuroAPI Header

X

Find the latest news about Celltrion aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Celltrion
korearepublicofnew Flag
Country
Country
South Korea
Address
Address
Yeonsu-gu, Incheon Metropolitan City
Telephone
Telephone

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/celltrion-usa-announces-incorporation-of-adalimumab-aaty-a-humira-biosimilar-to-the-costco-member-prescription-program-302220446.html

PR NEWSWIRE
12 Aug 2024

https://www.businesswire.com/news/home/20240801708617/en

BUSINESSWIRE
01 Aug 2024

https://www.biospectrumasia.com/news/25/24511/chinese-startup-hasten-biopharma-buys-14-products-from-korean-firm-celltrion-.html

BIOSPECTRUM ASIA
02 Jul 2024

https://www.businesswire.com/news/home/20240607689134/en

BUSINESSWIRE
13 Jun 2024

https://www.ema.europa.eu/en/documents/overview/omlyclo-epar-medicine-overview_en.pdf

EMA
29 May 2024

https://www.pharmaceutical-technology.com/news/ec-approves-celltrion-omlyclo/

PHARMACEUTICAL TECHNOLOGY
24 May 2024

https://www.businesswire.com/news/home/20240521556727/en

BUSINESSWIRE
23 May 2024

https://www.prnewswire.com/news-releases/zymfentra-infliximab-dyyb-demonstrated-long-term-efficacy-and-safety-profile-of-maintenance-treatment-through-two-years-for-adults-with-moderately-to-severely-active-crohns-disease-and-ulcerative-colitis-302150673.html

PR NEWSWIRE
21 May 2024

https://www.pharmiweb.com/press-release/2024-05-20/reality-tv-star-mollie-pearce-backs-campaign-to-tackle-inequalities-in-condition-that-impacts-millions-of-people-globally

PHARMIWEB
20 May 2024

https://www.businesswire.com/news/home/20240517193492/en

BUSINESSWIRE
18 May 2024
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY